HBAN vs IRMD · P/E 13, rev $1.56B vs P/E 51, rev $42.4M
Huntington Bancshares Incorporated (HBAN) versus Iradimed Co (IRMD) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Iradimed Co (IRMD) is a medical devices company listed on US.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported IRMD revenue for 2026-06-30 was $42.4M. Net income was $11.0M. Revenue was up 93.1% from 2026-03-31 to 2026-06-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Not investment advice. Open the HBAN and IRMD stock pages for the full models.
Not investment advice.